Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial-Reference-Cited by-同舟云学术

Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial

Published:2013-03 Issue:3 Volume:14 Page:199-209
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Vora Ajay,Goulden Nick,Wade Rachel,Mitchell Chris,Hancock Jeremy,Hough Rachael,Rowntree Clare,Richards Sue

Publisher

Elsevier BV

Subject

Oncology

Reference40 articles.

1. The impact of risk stratification by early bone-marrow response in childhood lymphoblastic leukaemia: results from the United Kingdom Medical Research Council trial ALL97 and ALL97/99;Mitchell;Br J Haematol,2009

2. Results of the Dana-Farber Cancer Institute ALL Consortium Protocol 95-01 for children with acute lymphoblastic leukemia;Moghrabi;Blood,2007

3. Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95;Moricke;Blood,2008

4. Improved outcome for children with acute lymphoblastic leukemia: results of Total Therapy Study XIIIB at St Jude Children's Research Hospital;Pui;Blood,2004

5. Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia;Cavé;N Engl J Med,1998

Cited by 411 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Are measurable residual disease results after consolidation therapy useful in children with acute lymphoblastic leukemia?;Leukemia;2024-09-10

2. CAR-T cells targeting CCR9 and CD1a for the treatment of T cell acute lymphoblastic leukemia;2024-09-03

3. Unlocking the Complexity: Exploration of Acute Lymphoblastic Leukemia at the Single Cell Level;Molecular Diagnosis & Therapy;2024-08-27

4. The Outcome of Modified St. Jude Total XV Protocol in Turkish Children with Newly Diagnosed Acute Lymphoblastic Leukemia: A Single-Center Retrospective Analysis;Turkish Journal of Hematology;2024-08-05

5. Measurable residual disease (MRD)-testing in haematological cancers: A giant leap forward or sideways?;Blood Reviews;2024-08